These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 694281)

  • 1. [Pharmacological basis of anti-anginal therapy. I. Physiopathological and pharmacological aspects (author's transl)].
    Penna M
    Rev Med Chil; 1978 Jul; 106(7):536-7. PubMed ID: 694281
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological basis of anti-anginal therapy. II. Effects of nitrites and beta blocking agents (author's transl)].
    Penna M
    Rev Med Chil; 1978 Jul; 106(7):543-51. PubMed ID: 29329
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of perhexiline on coronary hemodynamic and myocardial metabolic responses to tachycardia.
    Pepine CJ; Schang SJ; Bemiller CR
    Circulation; 1974 May; 49(5):887-93. PubMed ID: 4828610
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of anti-anginal and/or coronary vasodilator drugs on coronary as well as systemic hemodynamics, myocardial blood flow distribution during halothane anesthesia in dogs (author's transl)].
    Kohyama A
    Masui; 1981 Feb; 30(2):127-40. PubMed ID: 7277675
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological approaches to the therapy of angina.
    Parratt JR
    Adv Drug Res; 1974; 9():103-34. PubMed ID: 4156950
    [No Abstract]   [Full Text] [Related]  

  • 6. On the mode of action of antianginal drugs.
    Szekeres L
    Basic Res Cardiol; 1978; 73(2):133-46. PubMed ID: 26329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential selection of anti-anginal drugs in stable stenocardia in relation to the data of central and intracardiac hemodynamics].
    Manak NA; Laziuk DG; Karoza AE; Karpova IS; Prokopchuk VP
    Kardiologiia; 1992 Jan; 32(1):44-7. PubMed ID: 1614020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical management of patients with angina. Has first-line management changed?
    Chatterjee K; Rouleau JL; Parmley WW
    JAMA; 1984 Sep; 252(9):1170-6. PubMed ID: 6147425
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanism of the antianginal action of nonachlazine].
    Chumburidze VB
    Farmakol Toksikol; 1976; 39(1):46-50. PubMed ID: 943317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiopathology of angina and long term antianginal medication. Current concepts].
    Charlier R
    Nouv Presse Med; 1974 Nov; 3(37):2407-10. PubMed ID: 4156585
    [No Abstract]   [Full Text] [Related]  

  • 11. Organic nitrates in angina pectoris.
    Bogaert MG
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196: 25-. PubMed ID: 4626390
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental studies on relationship of chemical structure of protocatechuic acid derivatives and cardiac oxygen consumption and coronary flow (author's transl)].
    Zhang ZY; Han PF; Liang MD; Rao MR
    Yao Xue Xue Bao; 1980 Nov; 15(11):641-7. PubMed ID: 7257787
    [No Abstract]   [Full Text] [Related]  

  • 13. [Problems of combined therapy with cardiac glycosides and anti-anginal drugs (author's transl)].
    Klaus W
    Arzneimittelforschung; 1977; 27(3a):731-6. PubMed ID: 17417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating patients with persistent chest pain and no obstructive coronary artery disease.
    Beltrame JF; Ganz P
    JAMA; 2009 Aug; 302(6):622-3; author reply 623-4. PubMed ID: 19671898
    [No Abstract]   [Full Text] [Related]  

  • 15. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology and pharmacology of angina pectoris.
    Pitt B
    Adv Cardiol; 1979; 26():55-64. PubMed ID: 33541
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological properties of a new anti-anginal agent: amiodarone].
    Moret PR; Boufas D; Fournet PC
    Schweiz Med Wochenschr; 1969 Jul; 99(30):1090-5. PubMed ID: 5351143
    [No Abstract]   [Full Text] [Related]  

  • 18. Nebivolol in patients with coronary slow flow: the right drug for the right case?
    Fragasso G
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):296-7. PubMed ID: 19666431
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences in vasodilatory response to dipyridamole between patients with angina and normal coronary arteries and patients with successful coronary angioplasty.
    Finocchiaro ML; Buffon A; Beltrame JF; Lupi A; Conti E; Lanza GA; Cianflone D; Crea F; Maseri A
    Coron Artery Dis; 1995 Jun; 6(6):479-87. PubMed ID: 7551269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The physiopathological mechanisms of transient regional myocardial ischemia and the approach to therapy].
    Indolfi C; Chiariello M
    Cardiologia; 1991 Feb; 36(2):153-63. PubMed ID: 1751959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.